About
Technology
Issues
FAQ
Links
Official Page
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
